An engineered S1P chaperone attenuates hypertension and ischemic injury
Steven Swendeman(Boston Children's Hospital), Timothy Hla(American Red Cross), Eric Engelbrecht(University of Louisville), Anna Cantalupo(Icahn School of Medicine at Mount Sinai), Teresa Sánchez(Cornell University), Catherine H. Liu(Cornell University), Victoria A. Blaho(Discovery Institute), Andréane Cartier(Boston Children's Hospital), K. Yanagida(Boston Children's Hospital), Nathalie Burg(Hospital for Special Surgery), Annarita Di Lorenzo(Cardiovascular Institute Hospital), Jane E. Salmon(Intermountain Healthcare), Yi Zhang(Cornell University), Yuquan Xiong(Memorial Sloan Kettering Cancer Center), Hui Yuan(Chinese Academy of Sciences), Sylvain Galvani(Boston Children's Hospital), Yu Hisano(Osaka University), Hideru Obinata(Gunma University)
Cited by 113
Related Papers
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
|Pharmacological Reviews|2004|1.7k
An update on the biology of sphingosine 1-phosphate receptors
|Journal of Lipid Research|2014|514
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate
|Circulation Research|2008|474
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390